{
  "Variants Include": [
    {
      "Gene": "EIF2AK4",
      "variants": [
        {
          "HGVS": "NM_001382257.1:c.1234A>G",
          "cDNA Change": {
            "transcript": "NM_001382257.1",
            "ref": "A",
            "alt": "G",
            "position": "1234"
          },
          "Protein Change": {
            "ref": "K",
            "alt": "R",
            "position": "412"
          },
          "Description in input context": "c.1234A>G (p.K412R)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Amyotrophic Lateral Sclerosis",
    "MONDO": "MONDO:0003967"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunoblotting",
      "Material used": {
        "Material Source": "Patient-derived material",
        "Material Name": "Fibroblasts",
        "Description": "This study investigated the role of the EIF2AK4 gene variant in patient-derived fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001382257.1:c.1234A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Immunoblot analysis revealed a significant reduction in protein expression (approximately 60% of control) in fibroblasts carrying the c.1234A>G variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in text"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "A control plasmid expressing wild-type EIF2AK4 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "An empty vector served as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression between 80% and 120% of the control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 80% or greater than 120% of the control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}